Achieve Life Sciences' Reverse Merger Round

Achieve Life Sciences raised a round of funding on January 05, 2017. Investors include OncoGenex Pharmaceuticals.

Achieve Life Sciences (NASDAQ: ACHV) is a specialty pharmaceutical company focused on clinical and commercial development of cytisine, a selective nicotine receptor partial agonist currently in late-s…

Articles about Achieve Life Sciences' Reverse Merger Round: